ATE116547T1 - Alginsäure enthaltende arzneisuspension. - Google Patents

Alginsäure enthaltende arzneisuspension.

Info

Publication number
ATE116547T1
ATE116547T1 AT92400830T AT92400830T ATE116547T1 AT E116547 T1 ATE116547 T1 AT E116547T1 AT 92400830 T AT92400830 T AT 92400830T AT 92400830 T AT92400830 T AT 92400830T AT E116547 T1 ATE116547 T1 AT E116547T1
Authority
AT
Austria
Prior art keywords
suspension containing
algic acid
medicinal suspension
concentrations
medicinal
Prior art date
Application number
AT92400830T
Other languages
English (en)
Inventor
Herve Davin
Jacques Dubois
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Application granted granted Critical
Publication of ATE116547T1 publication Critical patent/ATE116547T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT92400830T 1991-03-29 1992-03-26 Alginsäure enthaltende arzneisuspension. ATE116547T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9103894A FR2674437B1 (fr) 1991-03-29 1991-03-29 Composition pharmaceutique, utile notamment dans le traitement d'affections gastro-óoesophagiennes.

Publications (1)

Publication Number Publication Date
ATE116547T1 true ATE116547T1 (de) 1995-01-15

Family

ID=9411310

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92400830T ATE116547T1 (de) 1991-03-29 1992-03-26 Alginsäure enthaltende arzneisuspension.

Country Status (7)

Country Link
EP (1) EP0506563B1 (de)
AT (1) ATE116547T1 (de)
DE (1) DE69201077T2 (de)
DK (1) DK0506563T3 (de)
ES (1) ES2067302T3 (de)
FR (1) FR2674437B1 (de)
GR (1) GR3015383T3 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5302373A (en) * 1993-06-10 1994-04-12 Church & Dwight Co., Inc. Liquid mouthwash containing a particulate bicarbonate suspension
NZ260933A (en) * 1993-07-16 1996-07-26 Hercules Inc Cation-complexed polysaccharides; use in foods and pharmaceuticals
EP0958246A2 (de) * 1997-02-10 1999-11-24 Tetra Werke Dr.rer.nat. Ulrich Baensch GmbH Zwei-komponentenmittel zur wasserklärung von tropischen zierfischaquarien
DE102004063612B4 (de) * 2004-01-02 2017-01-12 Manfred Helms Gelartiges Basenpräparat sowie Verwendung eines Gelbildners zu dessen Herstellung
DE102008019339A1 (de) * 2008-04-16 2009-10-22 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung für die medizinische Anwendung, insbesondere Antazidum
BR112019010671A8 (pt) 2016-11-28 2022-07-26 Currahee Holding Company Inc Composições líquidas que compreendem um agente mucoadesivo

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4744986A (en) * 1986-03-07 1988-05-17 Rorer Pharmaceutical Corporation Process for the preparation of a viscosity-stable antacid composition
AU627775B2 (en) * 1988-09-20 1992-09-03 Glaxo Group Limited Pharmaceutical compositions

Also Published As

Publication number Publication date
DE69201077D1 (de) 1995-02-16
DE69201077T2 (de) 1995-05-11
FR2674437B1 (fr) 1993-07-09
GR3015383T3 (en) 1995-06-30
EP0506563A1 (de) 1992-09-30
FR2674437A1 (fr) 1992-10-02
ES2067302T3 (es) 1995-03-16
DK0506563T3 (da) 1995-05-15
EP0506563B1 (de) 1995-01-04

Similar Documents

Publication Publication Date Title
NZ294464A (en) Stable, aqueous formulation having high biological alpha-type interferon activity buffered from 4.5 to 7.1 and comprising chelating agent and a polyoxyethylene sorbitan monooleate, formulation free from human blood-derived products
IT1178235B (it) Composizioni farmaceutiche contenenti sucralfat e procedimento per la loro stabilizzazione
FI945081A (fi) Stabiili hydratoitu kefalosporiinikuivajauhe oraaliseen suspensioformulaatioon
ATE148630T1 (de) Stabilisierte derivate von vitamin d2 und d3 enthaltende pharmazeutische zusammensetzungen
ES2055014T3 (es) Productos que contienen psyllium.
EP0136100A3 (en) Sucralfate suspension for use in treating ulcers
HUP9801414A2 (hu) Nátrium-alginátot és kálium-bikarbonátot tartalmazó folyékony vizes gyógyszerkészítmények
GB2090529A (en) Thrombosis-prophylactic and curing agent
DE69201077D1 (de) Alginsäure enthaltende Arzneisuspension.
DK0764023T3 (da) Forbindelser og præparater til administrering via oral inhalation eller insufflation
SE9403389D0 (sv) Pharmaceutical composition containing derivattves of sex hormones
SE8700157L (sv) Sett att forhindra kvicksilverforgiftning orsakad av upplosning av kvicksilver ur amalgamplomber samt komposition herfor

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee